KL
Kelyniam Global, Inc.
KLYG · OTC
$0.12 +0.00% (+$0.00)
1M -3.51%
Market Cap $1.51M
P/E Ratio -
Div. Yield -
ROE 29.31%
Bulios Fair Price
$0.13
8.3% upside
Current Price
$0.12
Undervalued Fair Value Overvalued
According to Bulios Fair Price, KLYG is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
75 /100
Cheap EV/EBITDA 11.84x
P/S 0.42x
P/B 2.20x
Growth
25 /100
Declining Rev. growth 0.39%
Book val. growth 2.23%
EPS growth N/A
Profitability
25 /100
Weak Gross margin 77.32%
Net margin 6.00%
Op. margin 3.35%
Quality
33 /100
Poor ROIC 8.32%
ROE 29.31%
ROA 12.84%
Debt
52 /100
Moderate Debt/Equity 0.56x
Current ratio 0.65x
Int. coverage 1.35x
Stability
30 /100
Unstable Beta -0.10x
Rev. volatility 19.93%
EPS volatility 127.29%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about KLYG
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Ross Bjella
Employees
9
Headquarters
Canton